Lee Ainslie's MANE Position Overview
Lee Ainslie (via Maverick Capital LTD) currently holds 789,980 shares of Veradermics, Incorporated (MANE) worth $97.12 M, representing 0.86% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Lee Ainslie has initiated a new position in MANE, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Lee Ainslie's Veradermics Incorporated (MANE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Veradermics Incorporated (MANE) Trades by Lee Ainslie
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +789,980 | New Buy | 789,980 | $122.94 |
Lee Ainslie's Veradermics Incorporated Investment FAQs
Lee Ainslie first purchased Veradermics, Incorporated (MANE) in Q2 2026, acquiring 789,980 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Lee Ainslie has held Veradermics, Incorporated (MANE) for 1 quarters since Q2 2026.
Lee Ainslie's largest addition to Veradermics, Incorporated (MANE) was in Q2 2026, adding 789,980 shares worth $97.12 M.
According to the latest 13F filing for Q2 2026, Lee Ainslie's firm, Maverick Capital LTD, owns 789,980 shares of Veradermics, Incorporated (MANE), valued at approximately $97.12 M.
As of the Q2 2026 filing, Veradermics, Incorporated (MANE) represents approximately 0.86% of Lee Ainslie's publicly disclosed stock portfolio, making it one of their key holdings.
Lee Ainslie's peak holding in Veradermics, Incorporated (MANE) was 789,980 shares, as reported at the end of Q2 2026.